What is BCYC's health score?

BICYCLE THERAPEUTICS PLC (BCYC) has a TradeApes health score of 45 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BCYC's estimated fair value?

Based on our 5-year discounted cash flow model, BICYCLE THERAPEUTICS PLC's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is BCYC undervalued or overvalued?

Our model currently rates BCYC as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BCYC... Refresh in a moment for the full analysis.

BICYCLE THERAPEUTICS PLC (BCYC)

Healthcare Inconclusive inconclusive mixed

$4.27

Updated: 2026-06-05

TradeApes Score

Financial Strength

40 Weak

Operating Trend

40 Weak

Relative Value

48 Mixed

Capital Allocation

30 Weak

Risk

80 Strong

Key Findings

+ Below historical median — trading below its own valuation average

Unlock Full Report →

− Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.